Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Site-wide government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:52:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were implemented, such as Show glossary and revision/version label changes (v3.4.0; No FEAR Act Data; Last Update Submitted that Met QC Criteria), with core study content unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:10:17.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a new revision note 'Revision: v3.3.4' and the previous 'Revision: v3.3.3' note was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:02:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new 'Locations' section is added with Pennsylvania listed as a site. The page footer shows revision v3.3.3, and the earlier 'Pennsylvania Locations' entry and 'HHS Vulnerability Disclosure' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the study page, with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:16:51.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Removal of the funding status notice about government operating status and potential processing delays.
    Difference
    0.4%
    Check dated 2025-11-17T18:42:10.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.